abstract |
The invention concerns medicaments containing at least one compound of formula (I) in which Ar designates an aryl group which is substituted one or more times, and R?1, R2 and R3¿ designate the substituents defined more closely in the claims. The medicaments are used for reducing the atherogenic lipoprotein Lp(a). |